Maravai LifeSciences (MRVI) Competitors $3.41 -0.07 (-2.01%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$3.41 0.00 (0.00%) As of 10/24/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRVI vs. AAPG, XENE, QURE, ZLAB, CGON, RARE, IRON, AMRX, APLS, and CNTAShould you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include Ascentage Pharma Group International (AAPG), Xenon Pharmaceuticals (XENE), uniQure (QURE), Zai Lab (ZLAB), CG Oncology (CGON), Ultragenyx Pharmaceutical (RARE), Disc Medicine (IRON), AMNEAL PHARMACEUTICALS (AMRX), Apellis Pharmaceuticals (APLS), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "pharmaceutical products" industry. Maravai LifeSciences vs. Its Competitors Ascentage Pharma Group International Xenon Pharmaceuticals uniQure Zai Lab CG Oncology Ultragenyx Pharmaceutical Disc Medicine AMNEAL PHARMACEUTICALS Apellis Pharmaceuticals Centessa Pharmaceuticals Maravai LifeSciences (NASDAQ:MRVI) and Ascentage Pharma Group International (NASDAQ:AAPG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk. Do institutionals and insiders hold more shares of MRVI or AAPG? 50.3% of Maravai LifeSciences shares are held by institutional investors. 2.1% of Maravai LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, MRVI or AAPG? Ascentage Pharma Group International has lower revenue, but higher earnings than Maravai LifeSciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaravai LifeSciences$259.18M3.36-$144.85M-$1.36-2.51Ascentage Pharma Group International$134.35M24.59-$55.54MN/AN/A Does the media favor MRVI or AAPG? In the previous week, Maravai LifeSciences had 1 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 2 mentions for Maravai LifeSciences and 1 mentions for Ascentage Pharma Group International. Ascentage Pharma Group International's average media sentiment score of 1.89 beat Maravai LifeSciences' score of 1.15 indicating that Ascentage Pharma Group International is being referred to more favorably in the news media. Company Overall Sentiment Maravai LifeSciences Positive Ascentage Pharma Group International Very Positive Is MRVI or AAPG more profitable? Ascentage Pharma Group International has a net margin of 0.00% compared to Maravai LifeSciences' net margin of -90.03%. Ascentage Pharma Group International's return on equity of 0.00% beat Maravai LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets Maravai LifeSciences-90.03% -17.60% -9.30% Ascentage Pharma Group International N/A N/A N/A Do analysts recommend MRVI or AAPG? Maravai LifeSciences presently has a consensus price target of $5.22, suggesting a potential upside of 53.04%. Given Maravai LifeSciences' higher probable upside, research analysts plainly believe Maravai LifeSciences is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Maravai LifeSciences 2 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAscentage Pharma Group International beats Maravai LifeSciences on 7 of the 13 factors compared between the two stocks. Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRVI vs. The Competition Export to ExcelMetricMaravai LifeSciencesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$888.66M$11.01B$6.24B$10.66BDividend YieldN/A1.88%5.71%4.82%P/E Ratio-2.5121.2330.4630.37Price / Sales3.3630.94595.13134.23Price / Cash5.6324.9837.0161.44Price / Book1.503.5012.046.60Net Income-$144.85M$210.63M$3.32B$276.82M7 Day Performance3.33%0.74%1.88%2.53%1 Month Performance26.77%3.10%7.68%3.71%1 Year Performance-51.42%-7.75%56.01%33.82% Maravai LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRVIMaravai LifeSciences3.8663 of 5 stars$3.41-2.0%$5.22+53.0%-52.2%$888.66M$259.18M-2.51610AAPGAscentage Pharma Group InternationalN/A$35.31-0.4%N/AN/A$3.30B$134.35M0.00600Positive NewsXENEXenon Pharmaceuticals2.5189 of 5 stars$43.44+4.3%$53.67+23.5%-2.6%$3.21B$9.43M-12.24210QUREuniQure2.7984 of 5 stars$63.92+10.2%$71.75+12.2%+841.5%$3.18B$27.12M-16.31500Analyst ForecastGap UpZLABZai Lab2.7361 of 5 stars$28.74+1.6%$56.35+96.1%-20.7%$3.16B$398.99M-14.091,869News CoverageAnalyst ForecastAnalyst RevisionCGONCG Oncology2.1114 of 5 stars$43.59+5.1%$58.82+34.9%+19.8%$3.16B$1.14M-24.6361Analyst ForecastRAREUltragenyx Pharmaceutical4.3829 of 5 stars$34.40+5.4%$81.50+136.9%-38.8%$3.15B$560.23M-6.221,294News CoverageAnalyst ForecastGap UpIRONDisc Medicine2.8374 of 5 stars$87.17-3.1%$108.73+24.7%+86.2%$3.13BN/A-19.5030Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeAMRXAMNEAL PHARMACEUTICALS2.4049 of 5 stars$10.24+3.2%$12.00+17.2%+27.0%$3.12B$2.79B1,025.038,100Analyst ForecastAPLSApellis Pharmaceuticals4.0866 of 5 stars$27.07+10.4%$33.47+23.6%+2.1%$3.10B$781.37M-14.87770News CoverageUpcoming EarningsAnalyst ForecastInsider TradeGap UpCNTACentessa Pharmaceuticals3.3915 of 5 stars$22.79-1.0%$32.38+42.1%+55.8%$3.08B$6.85M-12.73200News CoverageAnalyst Forecast Related Companies and Tools Related Companies AAPG Alternatives XENE Alternatives QURE Alternatives ZLAB Alternatives CGON Alternatives RARE Alternatives IRON Alternatives AMRX Alternatives APLS Alternatives CNTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRVI) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRVI Stock Alerts